NEDD4-mediated HSF1 degradation underlies α-synucleinopathy

  • Eunhee Kim
  • , Bin Wang
  • , Namratha Sastry
  • , Eliezer Masliah
  • , Peter T. Nelson
  • , Huaibin Cai
  • , Francesca Fang Liao

Research output: Contribution to journalArticlepeer-review

76 Scopus citations

Abstract

Cellular protein homeostasis is achieved by a delicate network of molecular chaperones and various proteolytic processes such as ubiquitin-proteasome system (UPS) to avoid a build-up of misfolded protein aggregates. The latter is a common denominator of neurodegeneration. Neurons are found to be particularly vulnerable to toxic stress from aggregation-prone proteins such as α-synuclein. Induction of heat-shock proteins (HSPs), such as through activated heat shock transcription factor 1 (HSF1) via Hsp90 inhibition, is being investigated as a therapeutic option for proteinopathic diseases. HSF1 is a master stressprotective transcription factor which activates genes encoding protein chaperones (e.g. iHsp70) and anti-apoptotic proteins. However, whether and how HSF1 is dysregulated during neurodegeneration has not been studied. Here, we discover aberrant HSF1 degradation by aggregated α-synuclein (or α-synuclein-induced proteotoxic stress) in transfected neuroblastoma cells. HSF1 dysregulation via α-synucleinwas confirmed by in vivo assessment of mouse and in situ studies of human specimens with α-synucleinopathy. We demonstrate that elevated NEDD4 is implicated as the responsible ubiquitin E3 ligase for HSF1 degradation through UPS. Furthermore, pharmacologically induced SIRT1-mediated deacetylation can attenuate aberrant NEDD4-mediated HSF1 degradation. Indeed, we define the acetylation status of the Lys 80 residue located in the DNA-binding domain of HSF1 as a critical factor in modulating HSF1 protein stability in addition to its previously identified role in the transcriptional activity. Together with the finding that preserving HSF1 can alleviate α-synuclein toxicity, this study strongly suggests that aberrant HSF1 degradation is a key neurodegenerative mechanism underlying α-synucleinopathy.

Original languageEnglish
Pages (from-to)211-222
Number of pages12
JournalHuman Molecular Genetics
Volume25
Issue number2
DOIs
StatePublished - Jan 15 2016

Bibliographical note

Publisher Copyright:
© The Author 2015. Published by Oxford University Press.

Funding

This work was supported by NIH grants R01 AG031893, R21 AG041934, R21 NS083908 to F.F.L, R37 AG18440 to E.M., R21 NS085830, P30 AG028383 to P.T.N., by Alzheimer Association grant IIRG-11-204040 to F.F.L. and by NIH intramural research program AG000929 to H.-B.C. Funding to pay the Open Access publication charges for this article was provided by NIH grant AG049772 to F.F.L.

FundersFunder number
National Institutes of Health (NIH)P30 AG028383, R21 AG041934, R21 NS085830, R01 AG031893, R21 NS083908
National Institutes of Health (NIH)
National Institute on AgingR37AG018440
National Institute on Aging
Alzheimer's AssociationAG049772, IIRG-11-204040, AG000929
Alzheimer's Association

    ASJC Scopus subject areas

    • Molecular Biology
    • Genetics
    • Genetics(clinical)

    Fingerprint

    Dive into the research topics of 'NEDD4-mediated HSF1 degradation underlies α-synucleinopathy'. Together they form a unique fingerprint.

    Cite this